NV-5138
NAV-17A-007
Phase 2 small_molecule completed
Quick answer
NV-5138 for Treatment Resistant Depression is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Treatment Resistant Depression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed